1 option
Cellular senescence in disease edited by Manuel Serrano, Daniel Muñoz-Espín
Elsevier ScienceDirect eBook - Biochemistry, Genetics and Molecular Biology 2021 Available online
View online- Format:
- Book
- Language:
- English
- Subjects (All):
- Pathology, Cellular.
- Age factors in disease.
- Cells--Aging.
- Cells.
- Age Factors.
- Cellular Senescence.
- Medical Subjects:
- Age Factors.
- Cellular Senescence.
- Physical Description:
- 1 online resource
- Place of Publication:
- London Academic Press 2022
- Contents:
- Front Cover
- Cellular Senescence in Disease
- Copyright
- Contents
- Contributors
- Foreword
- REFERENCES
- 1
- Fundamentals
- Cellular senescence: from old to new testament
- Old testament-genesis of senescence
- New testament-from mechanisms and roles of senescence to therapies
- Replicative senescence and telomeres
- Oncogene-induced senescence and tumor suppression
- Damage-induced senescence
- Hallmarks of cellular senescence
- SASP
- Senescence in physiology, repair, and embryonic development
- Senescence in aging and age-related disorders
- Prosenescent and antisenescent therapies
- Clinical trials
- References
- 2
- Cellular senescence in disease states
- Premalignant lesions and cellular senescence
- Introduction
- Cellular senescence in premalignant lesions: evidence in various organs
- Skin
- Head and neck
- Lungs
- Gastrointestinal tract
- Liver
- Pancreas
- Mammary gland
- Prostate gland
- Cervix
- Thyroid
- Future perspectives
- Further reading
- 3
- Lung aging and senescence in health and disease
- Normal lung development and aging
- A brief introduction to COPD and IPF
- Abnormal hallmarks of lung aging in COPD and IPF
- Cellular senescence
- Mitochondrial dysfunction
- Stem cell dysfunction
- Telomere dysfunction
- Epigenetic changes and miRNAs
- Loss of protein homeostasis (proteostasis)
- Deregulated nutrient sensing
- Extracellular matrix (ECM) dysregulation
- Future treatment targeting lung senescence
- Conclusions
- Supported
- Abbreviations
- 4
- Cell senescence in pulmonary hypertension
- Pulmonary hypertension, a non-aging-related proliferative vascular disorder at the crossroads of vascular disease and cancer
- General considerations about aging of the systemic and pulmonary vascular systems
- Considerations about constitutive cells of pulmonary vessels and the specificity of the pulmonary vasculature
- Potential mechanisms accounting for cell senescence in PH and PAH
- DNA damage is associated with PH
- Pulmonary artery smooth muscle cells (PASMCs)
- Pulmonary vascular endothelial cells (PECs)
- Genetic and environmental factors responsible for DNA damage in PAH
- The link between DNA damage, cell senescence, and PAH pathogenesis
- Alteration in the BMPR2/TGF beta pathway
- Hypoxia
- Drugs
- Shear stress
- HIV infection
- Role for senescent cells in PH and PAH
- General considerations
- Induction of lung cell senescence: effect on PH
- Treatment with nutlin
- Telomerase inactivation
- Induction of cell senescence by activation of signaling pathways involved in chronic lung diseases
- Prevention or protection against lung cell senescence: effect on PH
- Inactivation of p53, p21, p16
- Elimination of senescent cells in experimental PAH
- Conclusion
- 5
- Liver diseases fibrosis and cirrhosis
- Liver structure and function
- Liver diseases-epidemiology and clinical aspects
- Senescence during aging of the healthy liver
- Senescence in acute liver injury
- Senescence in chronic liver disease
- Role of senescence in hepatic dysfunction
- Evolutionary role of senescence in the liver
- Senescence during hepatic carcinogenesis
- Summary and closing comments
- 6
- Cellular senescence during aging and chronic liver diseases: mechanisms and therapeutic opportunities
- Cellular senescence in the liver
- Mechanisms contributing to cellular senescence in liver
- Autophagy impairment
- Mitochondrial dysfunction
- Fatty acids
- Oxidative stress
- Telomere shortening
- Growth hormone axis
- mTOR activity
- Altered microbiome
- Threshold theory of senescent cell burden
- Implications of senescence in obesity: downstream effects
- Inflammation
- Inhibition of adipogenesis and ectopic lipid deposition
- NAD+ depletion due to CD38+ macrophage attraction
- Obesity-induced neurocognitive defects
- Paracrine effects on neighboring cells
- Promotion of cancer development
- Reduced regenerative potential
- Strategies to target obesity-related senescent cells
- Exercise and weight loss
- Senolytics
- SASP inhibitors or senomorphics
- Administration schedule of senescence-targeting therapies
- 12
- A framework for addressing senescent cell burden in the osteoarthritic knee: therapeutics, immune signaling, a ...
- Main
- Knee tissues degenerate in osteoarthritis
- Chronic presence of senescent cells in the knee accelerates osteoarthritic erosion
- Killing senescent cells in the knee can reduce OA-associated dysfunction
- Translating antisenescent therapies to the clinic for OA treatment
- Competing interests
- 13
- Osteoporosis and bone loss
- Osteoporosis as a public health problem
- The hallmarks of aging in bone
- The role of cellular senescence in mediating age-related bone loss
- Identification of senescent cells in the bone microenvironment
- Causal role for cellular senescence in mediating age-related bone loss
- Role of cellular senescence in mediating age-related frailty
- Estrogen deficiency and cellular senescence
- The role of cellular senescence in the effects of diabetes mellitus on bone
- Cellular senescence and radiation- and chemotherapy-induced bone loss
- Other Format:
- Print version:
- ISBN:
- 9780128225158
- 0128225157
- OCLC:
- 1286954501
- Access Restriction:
- Restricted for use by site license
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.